LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H (HK:2291) has released an update.
LEPU ScienTech Medical Technology, a notable Chinese medical technology firm, has announced changes to its board of directors and committee roles effective December 9, 2024. The company outlined the new structure of its executive, non-executive, and independent non-executive directors, as well as their respective positions in the audit, remuneration, and nomination committees. These changes are expected to steer the company’s strategic direction and governance.
For further insights into HK:2291 stock, check out TipRanks’ Stock Analysis page.